Atorvastatin may increase the myopathic rhabdomyolysis activities of Trabectedin. The risk or severity of adverse effects can be increased when Acetazolamide is combined with Atorvastatin. The serum concentration of Atorvastatin can be decreased when it is combined with Dabrafenib. The metabolism of Atorvastatin can be increased when combined with Rifabutin. The serum concentration of Atorvastatin can be increased when it is combined with Cyclosporine. The risk or severity of adverse effects can be increased when Tacrolimus is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Clozapine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Clemastine is combined with Atorvastatin. The metabolism of Atorvastatin can be decreased when combined with Trimethoprim. The risk or severity of adverse effects can be increased when Amrinone is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Tesmilifene is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Atomoxetine is combined with Atorvastatin. Atorvastatin may increase the hypoglycemic activities of Glisoxepide. The serum concentration of Atorvastatin can be increased when it is combined with Aprotinin. The risk or severity of adverse effects can be increased when Delavirdine is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Benazepril. The risk or severity of adverse effects can be increased when Clomifene is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Argatroban. The serum concentration of Aliskiren can be increased when it is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Alpha-1-proteinase inhibitor. The risk or severity of adverse effects can be increased when Glyburide is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Methysergide is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Vinblastine is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Gabexate. The risk or severity of adverse effects can be increased when Lacidipine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Azelastine is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Saxagliptin. The serum concentration of Dabigatran etexilate can be decreased when it is combined with Atorvastatin. The serum concentration of Ubidecarenone can be increased when it is combined with Atorvastatin. The serum concentration of Atorvastatin can be decreased when it is combined with Bismuth Subcitrate. The serum concentration of Mevastatin can be increased when it is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Ubenimex. Azithromycin may increase the myopathic rhabdomyolysis activities of Atorvastatin. The risk or severity of adverse effects can be increased when Cabergoline is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Dronedarone. The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Candoxatrilat. The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Ombitasvir. Atorvastatin may increase the anticoagulant activities of Phenindione. The risk or severity of adverse effects can be increased when Darodipine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Nicardipine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Sulfisoxazole is combined with Atorvastatin. The serum concentration of Atorvastatin can be decreased when it is combined with Etravirine. The serum concentration of Atorvastatin can be increased when it is combined with Fosinopril. The risk or severity of adverse effects can be increased when Amlodipine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Caffeine is combined with Atorvastatin. The serum concentration of Atorvastatin can be decreased when it is combined with Almasilate. The risk or severity of adverse effects can be increased when Risperidone is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Propofol is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Netupitant is combined with Atorvastatin. The serum concentration of Atorvastatin can be decreased when it is combined with Aluminium. The serum concentration of Atorvastatin can be decreased when it is combined with Colestipol. The risk or severity of adverse effects can be increased when Ravuconazole is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Atorvastatin is combined with Cimetidine. The serum concentration of Atorvastatin can be increased when it is combined with 3,4-Dichloroisocoumarin. The serum concentration of Atorvastatin can be increased when it is combined with Rivaroxaban. The risk or severity of adverse effects can be increased when Pimozide is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Lumacaftor. The serum concentration of Metoprolol can be increased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Aldesleukin is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Teriflunomide. The serum concentration of Atorvastatin can be increased when it is combined with Abiraterone. The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Tolfenamic Acid is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Flunarizine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Imatinib is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Capsaicin is combined with Atorvastatin. Atorvastatin may increase the hypoglycemic activities of Glibornuride. The risk or severity of adverse effects can be increased when Olanzapine is combined with Atorvastatin. The serum concentration of Digoxin can be increased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Progesterone is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Z-Val-Ala-Asp fluoromethyl ketone. The serum concentration of Atorvastatin can be increased when it is combined with Moexipril. The risk or severity of adverse effects can be increased when Cinnarizine is combined with Atorvastatin. The metabolism of Atorvastatin can be increased when combined with Secobarbital. Atorvastatin may increase the hypoglycemic activities of Chlorpropamide. The serum concentration of Atorvastatin can be decreased when it is combined with Tocilizumab. The risk or severity of adverse effects can be increased when Anastrozole is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Simeprevir. The risk or severity of adverse effects can be increased when Benidipine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Diethylstilbestrol is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Nimesulide is combined with Atorvastatin. Atorvastatin may increase the hypoglycemic activities of Gliquidone. The risk or severity of adverse effects can be increased when Albaconazole is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Mibefradil is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Troleandomycin is combined with Atorvastatin. The metabolism of Atorvastatin can be increased when combined with Rifapentine. The serum concentration of Aripiprazole can be decreased when it is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Perindopril. The serum concentration of Atorvastatin can be increased when it is combined with Itraconazole. The risk or severity of adverse effects can be increased when Lidocaine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Losartan is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Ezetimibe is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Cisapride is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Doxycycline is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Bromocriptine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Daunorubicin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Niguldipine is combined with Atorvastatin. The serum concentration of Silodosin can be increased when it is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Candoxatril. The risk or severity of adverse effects can be increased when Caspofungin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Lysergic Acid Diethylamide is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Histamine is combined with Atorvastatin. The serum concentration of Atorvastatin can be decreased when it is combined with Mitotane. The risk or severity of adverse effects can be increased when Sulconazole is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Mefloquine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Terconazole is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Ximelagatran. The risk or severity of adverse effects can be increased when Sorafenib is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Epigallocatechin Gallate. The risk or severity of adverse effects can be increased when Xylometazoline is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Rivastigmine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Fidaxomicin is combined with Atorvastatin. The serum concentration of Bosutinib can be increased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Tramadol is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Fluoxetine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Efonidipine is combined with Atorvastatin. Atorvastatin may increase the anticoagulant activities of Ethyl biscoumacetate. The serum concentration of Atorvastatin can be increased when it is combined with Osimertinib. The risk or severity of adverse effects can be increased when Clotrimazole is combined with Atorvastatin. The metabolism of Atorvastatin can be decreased when combined with Crisaborole. The risk or severity of adverse effects can be increased when Pilocarpine is combined with Atorvastatin. The metabolism of Atorvastatin can be increased when combined with Carbamazepine. The risk or severity of adverse effects can be increased when Desipramine is combined with Atorvastatin. The serum concentration of Thioridazine can be increased when it is combined with Atorvastatin. The serum concentration of Atorvastatin can be decreased when it is combined with Siltuximab. The risk or severity of adverse effects can be increased when Etoposide is combined with Atorvastatin.